Results 191 to 200 of about 23,326 (221)

Atypical presentation of DRESS/DiHS mimicking an acquired ichthyosis: A case report of bortezomib-induced severe erythroderma in multiple myeloma. [PDF]

SAGE Open Med Case Rep
Lu C, Belmesk L, Bélisle A, Masse MS, Ouellette S, Cote B.   +5 more
europepmc   +1 more source

Dupilumab for bullous pemphigoid: Umbrella review of systematic reviews and meta-analyses. [PDF]

JAAD Int
Thapa M, Green B, Kasperkiewicz M.
europepmc   +1 more source

Comparative analysis of the manufacturing carbon footprint of biologics for severe asthma. [PDF]

BMJ Open
Taylor H, Rahman N.
europepmc   +1 more source

Cost-Effectiveness Analysis of Abrocitinib Compared with Dupilumab for Adolescents With Severe Atopic Dermatitis in Spain. [PDF]

Pharmacoecon Open
Romero Jiménez RM, Herranz Pinto P, Campos Domínguez M, Bellmunt A, Vidal-Vilar N, Fortes Soto MDP, De Lossada Juste A.   +6 more
europepmc   +1 more source

Concurrent Nemolizumab-Induced Cutaneous Adverse Events and Asthma Exacerbation in a Patient With Prurigo Nodularis With Resolution of Both Conditions After Switching to Dupilumab. [PDF]

Cureus
Mima Y, Yamamoto M, Iozumi K.
europepmc   +1 more source

Distinct Effects of Biological Treatments on Eosinophils and Neutrophils in Chronic Rhinosinusitis With Nasal Polyp Patients. [PDF]

Clin Transl Allergy
Van Nevel S, Zhang N, Xu Z, Blauwblomme M, Vandewalle E, Holtappels G, De Ruyck N, Van Nieuwerburgh F, Vanhee S, Gevaert P, Bachert C.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Dupilumab

Reactions Weekly
  +19 more sources

Dupilumab

Reactions Weekly, 2023
  +10 more sources

Dupilumab

Reactions Weekly, 2022
  +7 more sources

Dupilumab‐induced Urticaria

Dermatologic Therapy, 2021
Mastorino L., Ortoncelli M., Virginia B., Rolla G., Avallone G., Cavaliere G., Riccardo V., Quaglino P., Ribero S.   +8 more
openaire   +3 more sources